Technology
Health
Pharmaceutical

Allergan

$153.67
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.41 (-0.27%) Today
-$0.02 (-0.01%) After Hours

Why Robinhood?

You can buy or sell Allergan and other stocks, options, ETFs, and crypto commission-free!

About

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. Read More The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded on in 1984 and is headquartered in Dublin, Ireland.

Employees
16,900
Headquarters
Dublin, Dublin
Founded
1984
Market Cap
51.25B
Price-Earnings Ratio
Dividend Yield
2.15
Average Volume
2.46M
High Today
$154.66
Low Today
$152.74
Open Price
$153.99
Volume
696.35K
52 Week High
$197.00
52 Week Low
$125.84

Collections

Technology
Health
Pharmaceutical
Therapy
Medical
Europe (Non-UK)
Europe

News

Barron's11m

Allergan Stock Won’t Benefit From a Breakup, Analyst Says

Text size Allergan stock (AGN) is up modestly on Wednesday afternoon, after one analyst warned that breaking up the company “is by no means a panacea.” The back story. Allergan stock is up 15% year to date, helped by the Food and Drug Administration’s acceptance of two of the company’s applications to expand applications of Botox, which overshadowed a setback in its major depressive disorder (MDD) franchise. The shares were also helped by stock purchases by its CEO and general enthusiasm for drugmakers, w...

2
PR Newswire5h

CoolSculpting® and Sonja Morgan Partner to Talk Bikini Denial

DUBLIN, March 20, 2019 /PRNewswire/ -- Television personality on Bravo's "The Real Housewives of New York City", philanthropist, fashion lifestyle entrepreneur and mom, Sonja Morgan, continues her partnership with CoolSculpting, owned by Allergan plc, to talk about "Bikini Denial.

10
MarketWatch6h

Allergan PLC Stock Quote (U.S.: NYSE)

Allergan Plc shares fell 3% in premarket trade Tuesday, after it swung to a loss in the fourth quarter and offered guidance for 2019 that was short of estimates.

2

Earnings

$3.36
$3.86
$4.36
$4.86
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Apr 29, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.